Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)-Reference-Cited by-同舟云学术

Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)

Published:2022-12-30 Issue:1 Volume:66 Page:657-676
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Puri Sachin¹^ORCID,Stefan Katja²^ORCID,Khan Sharuk L.³^ORCID,Pahnke Jens²⁴⁵^ORCID,Stefan Sven Marcel²⁴^ORCID,Juvale Kapil¹^ORCID

Affiliation:

1. Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai400056, India

2. Department of Pathology, Section of Neuropathology, Translational Neurodegeneration Research and Neuropathology Lab (www.pahnkelab.eu), University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372Oslo, Norway

3. Department of Pharmaceutical Chemistry, N.B.S. Institute of Pharmacy, Ausa413520, Maharashtra, India

4. Drug Development and Chemical Biology Lab, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23538Lübeck, Germany

5. Department of Pharmacology, Faculty of Medicine, University of Latvia, Jelgavas iela 4, 1004Ri̅ga, Latvia

Funder

Helse S?r-?st RHF

Nasjonalforeningen for Folkehelsen

Barnekreftforeningen

Agence Nationale de la Recherche

Bundesministerium f?r Bildung und Forschung

Science and Engineering Research Board

?sterreichische Forschungsf?rderungsgesellschaft

Norges Forskningsr?d

Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy

Deutsche Forschungsgemeinschaft